Hypertension Diagnostics Stock Net Income
| HDII Stock | USD 0.0001 0.00 0.00% |
Hypertension Diagnostics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Hypertension Diagnostics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Hypertension Diagnostics' valuation are provided below:Hypertension Diagnostics does not presently have any fundamental trends for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Hypertension |
Hypertension Diagnostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Hypertension Diagnostics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Hypertension Diagnostics.
| 10/26/2025 |
| 01/24/2026 |
If you would invest 0.00 in Hypertension Diagnostics on October 26, 2025 and sell it all today you would earn a total of 0.00 from holding Hypertension Diagnostics or generate 0.0% return on investment in Hypertension Diagnostics over 90 days. Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that... More
Hypertension Diagnostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Hypertension Diagnostics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Hypertension Diagnostics upside and downside potential and time the market with a certain degree of confidence.
Hypertension Diagnostics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hypertension Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Hypertension Diagnostics' standard deviation. In reality, there are many statistical measures that can use Hypertension Diagnostics historical prices to predict the future Hypertension Diagnostics' volatility.Hypertension Diagnostics Backtested Returns
We have found three technical indicators for Hypertension Diagnostics, which you can use to evaluate the volatility of the firm. The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Hypertension Diagnostics are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Hypertension Diagnostics has perfect predictability. Overlapping area represents the amount of predictability between Hypertension Diagnostics time series from 26th of October 2025 to 10th of December 2025 and 10th of December 2025 to 24th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Hypertension Diagnostics price movement. The serial correlation of 1.0 indicates that 100.0% of current Hypertension Diagnostics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Hypertension Diagnostics reported net income of (125,388). This is 100.01% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 100.02% higher than that of the company.
Hypertension Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hypertension Diagnostics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Hypertension Diagnostics could also be used in its relative valuation, which is a method of valuing Hypertension Diagnostics by comparing valuation metrics of similar companies.Hypertension Diagnostics is currently under evaluation in net income category among its peers.
Hypertension Fundamentals
| Return On Asset | 3.0E-4 | |||
| Profit Margin | (0.03) % | |||
| Operating Margin | 0.0002 % | |||
| Current Valuation | 5.26 M | |||
| Shares Outstanding | 52.39 M | |||
| Price To Earning | (0.03) X | |||
| Price To Sales | 0.15 X | |||
| Revenue | 3.79 M | |||
| Gross Profit | 954.47 K | |||
| EBITDA | 72.29 K | |||
| Net Income | (125.39 K) | |||
| Cash And Equivalents | 5.66 K | |||
| Total Debt | 4.69 M | |||
| Current Ratio | 0.52 X | |||
| Book Value Per Share | (0.09) X | |||
| Cash Flow From Operations | (389.28 K) | |||
| Earnings Per Share | (0) X | |||
| Beta | -0.92 | |||
| Market Capitalization | 730.42 K | |||
| Total Asset | 1.28 M | |||
| Retained Earnings | (30.68 M) | |||
| Working Capital | (857 K) | |||
| Current Asset | 277 K | |||
| Current Liabilities | 1.13 M | |||
| Z Score | -31.6 | |||
| Net Asset | 1.28 M |
About Hypertension Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hypertension Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hypertension Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hypertension Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Hypertension Pink Sheet
Hypertension Diagnostics financial ratios help investors to determine whether Hypertension Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hypertension with respect to the benefits of owning Hypertension Diagnostics security.